FDA Does Not Approve Immune Disorder Gene Therapy

Rocket Pharmaceuticals said on Friday the U.S. health regulator declined to approve its gene therapy to treat a rare and severe pediatric disorder that causes the immune system to malfunction, sending its shares down more than 12% in early trading. The Food and Drug…

Related articles

You may also be interested in

House Republicans Disavow Project 2025

As House Democrats try to tie Republicans to Project 2025, House Republicans are distancing themselves from Heritage Foundation’s blueprint for a potential second term for

Obama Hosting High-Dollar Fundraiser for Harris

Former President Barack Obama is hosting a high-dollar fundraiser for Vice President Kamala Harris this Friday in his first campaign event for the Democrat nominee.[#item_full_content]

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.